| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 09/01/1992 | US5143844 Construction of an igg binding protein to facilitate downstream processing using protein engineering | 
| 09/01/1992 | US5143830 Process for the production of a polypeptide | 
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed | 
| 09/01/1992 | CA1306966C Human monocytes cultured in suspension in serum-free medium | 
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins | 
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein | 
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides | 
| 08/28/1992 | WO1992015682A1 Serine-rich peptide linkers | 
| 08/28/1992 | CA2061918A1 Pharmaceutical compositions comprising a lymphokine | 
| 08/27/1992 | CA2061797A1 Fermentation processes | 
| 08/27/1992 | CA2061721A1 Vector containing an inducible selection gene system | 
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation | 
| 08/26/1992 | EP0500311A2 Biologically active bacillus thuringiensis isolates and gene encoding a cleopteran-active toxin | 
| 08/26/1992 | EP0500236A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents | 
| 08/26/1992 | EP0500108A2 Improved activation of recombinant proteins | 
| 08/26/1992 | EP0499993A2 Method for producing human nerve growth factor-2 | 
| 08/26/1992 | EP0499990A2 Method for producing cysteine-free peptides | 
| 08/26/1992 | EP0499837A1 A defined coating of fusion proteins from a constant fusion partner and a variable antigenic part in diagnostic test systems | 
| 08/26/1992 | EP0499834A2 A blood-stage antigen from Plasmodium falciparum, its preparation and use | 
| 08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use | 
| 08/26/1992 | EP0483219A4 Enhancement of musculature in animals | 
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification | 
| 08/26/1992 | EP0229809B1 Animal cell culture | 
| 08/26/1992 | CA2061633A1 Yeast vectors | 
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule | 
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna | 
| 08/25/1992 | US5142028 Can be used for elucidation of sugar chain roles in cell functions | 
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds | 
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor | 
| 08/25/1992 | US5141806 Chromatographic packing, activated catalysts | 
| 08/25/1992 | US5141736 Bispecific monoclonal antibody, its production and use | 
| 08/25/1992 | CA1306709C Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | 
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody | 
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer | 
| 08/25/1992 | CA1306689C Method of preparing a vaccine against hepatitis b and the vaccine thus obtained | 
| 08/22/1992 | CA2061575A1 Plasmodium falciparum blood-stage antigen, the preparation and use thereof | 
| 08/22/1992 | CA2061574A1 Defined coating with recombinant fusion proteins composed of constant fusion partner and variable antigen portion in diagnostic test systems | 
| 08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences | 
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites | 
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof | 
| 08/20/1992 | WO1992013964A1 Protein preparations | 
| 08/20/1992 | WO1992013955A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules | 
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | 
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof | 
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family | 
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS | 
| 08/20/1992 | WO1992013892A1 Monoclonal antibodies to putative hcv envelope region and methods for using same | 
| 08/20/1992 | WO1992013890A1 Nematode vaccine | 
| 08/20/1992 | WO1992013889A1 Nematode vaccine | 
| 08/20/1992 | WO1992013884A1 Liver-stage-specific peptide sequences of p. falciparum bearing epitopes capable of stimulating the t lymphocytes | 
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors | 
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides | 
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing | 
| 08/20/1992 | WO1992013550A1 Recombinant transferrins, transferrin half-molecules and mutants thereof | 
| 08/20/1992 | WO1992007940A3 Bovine respiratory syncytial virus genes | 
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant | 
| 08/20/1992 | WO1992001782A3 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells | 
| 08/20/1992 | CA2638662A1 Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes | 
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites | 
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing | 
| 08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences | 
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors | 
| 08/20/1992 | CA2079871A1 Vaccine | 
| 08/20/1992 | CA2079870A1 Vaccine | 
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same | 
| 08/19/1992 | EP0499541A1 Process for the purification of a highly glycosylated protein | 
| 08/19/1992 | EP0499306A1 Starches with an improved flavour | 
| 08/19/1992 | EP0499260A2 Procedure for hydrolyzing keratin | 
| 08/19/1992 | EP0499176A2 Monoclonal antibodies against human pancreatic islet cells | 
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies | 
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor | 
| 08/19/1992 | EP0499010A1 A method for measuring the activity of angiotensin converting enzyme in biological samples | 
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis | 
| 08/19/1992 | EP0498858A1 Nested-cone separator | 
| 08/19/1992 | EP0472638A4 Method for isolating receptors having a preselected specificity | 
| 08/19/1992 | EP0449956A4 Novel lymphokine/cytokine genes | 
| 08/19/1992 | EP0425661A4 A new method for tapping the immunological repertoire | 
| 08/19/1992 | EP0314744B1 Monokine dosing | 
| 08/19/1992 | EP0153961B1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof | 
| 08/19/1992 | CN1017867B Method of preparing covaluently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic protein | 
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption | 
| 08/18/1992 | US5140101 Antiviral antibiotic BU-4344V | 
| 08/18/1992 | US5139938 Production of substances with an acetic acid-producing and assimilating bacterium inhibited by acetic acid | 
| 08/18/1992 | US5139937 Process for producing apoaequorin | 
| 08/18/1992 | CA1306582C Synthetic polypeptides for detecting mycobacterial infections | 
| 08/18/1992 | CA1306430C Monoclonal antibody | 
| 08/18/1992 | CA1306429C Monoclonal antibodies specific for equine chorionic gonadotrophin | 
| 08/18/1992 | CA1306428C Monoclonal antibody specific for a mammary tumor cell surface antigen | 
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein | 
| 08/16/1992 | CA2061266A1 Recombinant dna molecules coding for a sequence of the t-cell antigen receptor, process for its preparation, and antibodies and medicament containing them | 
| 08/15/1992 | CA2061156A1 Procedure for hydrolyzing keratin | 
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) | 
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies | 
| 08/12/1992 | EP0498452A2 Process for the production of protease C | 
| 08/12/1992 | EP0498124A1 Monoclonal antibodies to mite allergen and the use thereof | 
| 08/12/1992 | EP0497922A1 Infective protein delivery system | 
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production | 
| 08/12/1992 | EP0497897A1 Diagnosis of glomerulonephritis | 
| 08/12/1992 | EP0497894A1 Receptor infection assay | 
| 08/12/1992 | EP0497884A1 Glutamate receptor compositions and methods |